| Product NDC: | 0069-1530 |
| Proprietary Name: | Norvasc |
| Non Proprietary Name: | AMLODIPINE BESYLATE |
| Active Ingredient(s): | 5 mg/1 & nbsp; AMLODIPINE BESYLATE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0069-1530 |
| Labeler Name: | Pfizer Laboratories Div Pfizer Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019787 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19920731 |
| Package NDC: | 0069-1530-72 |
| Package Description: | 300 TABLET in 1 BOTTLE (0069-1530-72) |
| NDC Code | 0069-1530-72 |
| Proprietary Name | Norvasc |
| Package Description | 300 TABLET in 1 BOTTLE (0069-1530-72) |
| Product NDC | 0069-1530 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | AMLODIPINE BESYLATE |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19920731 |
| Marketing Category Name | NDA |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Substance Name | AMLODIPINE BESYLATE |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] |